3925319

Glioblastoma organoids model extracellular matrix heterogeneity

Date
August 13, 2023
Explore related products in the following collection:

Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults with a prognosis of 12-15 months. The aggressiveness of GBM is highly attributed to its heterogeneity of the tumor microenvironment (TME). Current in vitro models of GBM offer limited translation to in vivo tumors because of the heterogeneous TME, leading to limited progress in drug development and treatment. Organoids are millimeter-scale, 3D in vitro modeling systems that recapitulate stem cell differentiation into highly organized, heterogeneous in vivo organ-like systems. Here, we used defined engineering parameters on single GSCs to grow and develop into GBM organoids (GBOs) with a diameter up to 4.0 mm in 3 months or less, without the use of media-induced differentiation or extracellular matrix (ECM) mimicking scaffolds. We found our GBOs self-induced differentiation and organized cells into some key components of the GBM TME (i.e. hypoxic niche, angiogenesis, and necrotic core). Interestingly, the GBOs also self-secreted and organized its own key ECM components (i.e. collagen IV, elastin, laminin, and hyaluronic acid). Through our studies, we aim to understand what induces GSC differentiation and ECM redesign to form the heterogeneous TME and how this dynamic TME leads to varying drug response.

Speakers

Speaker Image for Y. John Kim
The University of Alabama

Related Products

Thumbnail for Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing
Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing
Core fucosylation is a highly prevalent and significant feature of _N_-glycosylation in therapeutic monoclonal antibodies produced by mammalian cells where its absence (afucosylation) plays a key role in patient treatment safety and efficacy…
Thumbnail for TCA cycle metabolites improve CHO cell culture performance in batch and fed-batch cultures
TCA cycle metabolites improve CHO cell culture performance in batch and fed-batch cultures
Mammalian cells are widely used in the pharmaceutical industry to produce vaccines and recombinant protein products such as monoclonal antibodies (mAbs)…
Thumbnail for Using 13C Metabolic Flux Analysis to understand metabolic bottlenecks in high and low IgG producing CHO Clones
Using 13C Metabolic Flux Analysis to understand metabolic bottlenecks in high and low IgG producing CHO Clones
Metabolic flux analysis (MFA) can be used to understand metabolic signatures of CHO clones and identify bottlenecks for antibody productions. MFA utilizes 13C-labelled glucose in upstream process to quantitatively track metabolic flux in each pathway…
Thumbnail for Heritable slowly co-fluctuating gene expression patterns are associated with stress resistance and improved productivity in CHO cell lines
Heritable slowly co-fluctuating gene expression patterns are associated with stress resistance and improved productivity in CHO cell lines
Many therapeutic proteins are produced using the Chinese hamster ovary (CHO) cell line due to their natural genetic plasticity, human-like post translational modifications, and superior production of secreted proteins…